Home › Funds › Ghisallo Capital Management LLC › NTLA
Ghisallo Capital Management LLC position in NTLA
INTELLIA THERAPEUTICS INC · Health Care
Ghisallo Capital Management LLC reported holding 1,000,000 shares of NTLA (INTELLIA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.1M, representing 0.28% of its reported portfolio and ranking #43 among its reported holdings. Ghisallo Capital Management LLC has disclosed NTLA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ghisallo Capital Management LLC's NTLA position evolved
Ghisallo Capital Management LLC first disclosed a stake in NTLA in Q2 2026 at 1,200,000 shares (US$20.3M). Across 2 filings, Ghisallo Capital Management LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,000,000 shares valued at US$12.1M — a reduction of -200,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.20M | $20.30M | New |
| Q3 2026 | 1.00M | $12.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NTLA and 13F data
NTLA (INTELLIA THERAPEUTICS INC) is a Health Care company. 30 other funds we track also report a position in NTLA — the largest reported positions include ARK Invest (US$192.1M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$44.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTLA
- ARK Invest 15.93M sh · $192.06M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 4.53M sh · $76.60M · Q2 2026
- REGENERON PHARMACEUTICALS, INC. 3.70M sh · $44.66M · Q3 2026
- Amova Asset Management Americas, Inc. 3.61M sh · $43.51M · Q3 2026
- Contrarius Group Holdings Ltd 2.43M sh · $29.33M · Q3 2026
- ARMISTICE CAPITAL, LLC 2.36M sh · $28.51M · Q3 2026
More on Ghisallo Capital Management LLC
FAQ
How long has Ghisallo Capital Management LLC held NTLA?
Ghisallo Capital Management LLC has disclosed NTLA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Ghisallo Capital Management LLC's current position in NTLA?
As of Q3 2026, Ghisallo Capital Management LLC holds 1.00M shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $12.06M, representing 0.28% of its reported portfolio and ranking #43.
Has Ghisallo Capital Management LLC been buying or selling NTLA?
In the latest 13F filing (Q3 2026), Ghisallo Capital Management LLC reduced its position in NTLA.
Which other funds hold NTLA?
Other major institutional holders of NTLA include ARK Invest, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.